Development and validation of a clinical risk score to predict mortality after percutaneous coronary intervention

Joshua J S Wall1,2, Javaid Iqbal1,2, Michael Andrews1,2

  • 1Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.

Open Heart
|September 8, 2017
PubMed

Insights

A new clinical risk score accurately predicts 30-day mortality after percutaneous coronary intervention (PCI). This score uses key patient factors available before the procedure, aiding clinical decision-making.

Area of Science:

  • Cardiology
  • Clinical Risk Prediction
  • Health Outcomes Research

Background:

  • Percutaneous coronary intervention (PCI) is a common procedure for coronary artery disease.
  • Predicting mortality after PCI is crucial for patient management and resource allocation.
  • Existing risk scores may not reflect contemporary patient populations or procedural techniques.

Purpose of the Study:

  • To develop and validate a clinical risk score for predicting 30-day mortality following PCI.
  • To identify key pre-procedural clinical variables associated with post-PCI mortality.
  • To create a tool that is easily applicable in routine clinical practice.

Main Methods:

  • Development of a risk score using logistic regression on data from 6522 patients undergoing PCI.
  • Identification of significant predictors: cardiogenic shock, procedural urgency, renal disease, diabetes mellitus, and age.
  • Internal validation on 3290 patients and external validation on 3230 patients from different UK centers.

Main Results:

  • The developed risk score demonstrated high predictive accuracy (C-statistic=0.82 in development, 0.81 internally, 0.90 externally).
  • Five clinical variables (cardiogenic shock, procedural urgency, renal disease, diabetes, age) were significant predictors of 30-day mortality.
  • No significant difference was observed between predicted and actual mortality rates across all cohorts.

Conclusions:

  • A contemporary clinical risk score effectively predicts 30-day mortality after PCI.
  • The score utilizes readily available pre-procedural clinical variables, independent of coronary anatomy.
  • This tool offers a reliable method for risk stratification in patients undergoing PCI.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
572
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
321
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
324